Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
High-cited favorable studies for COVID-19 treatments ineffective in large trials — John P A Ioannidis (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
High-cited favorable studies for COVID-19 treatments ineffective in large trials
Shared by
John P A Ioannidis
Stanford University
High-cited favorable studies for COVID-19 treatments ineffective in large trials
Article
2022
en
Related publications
Preprint
2022
High-cited favorable studies for COVID-19 treatments ineffective in large trials
John P A Ioannidis
Article
2021
COVID-19: A Catalyst for Transforming Randomized Trials
Jennifer Lee
,
Jerri C. Price
,
William M. Jackson
,
Robert A. Whittington
,
John P A Ioannidis
Authors
John P A Ioannidis
Stanford University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2022
Organoid Studies in COVID-19 Research
Jihoon Kim
,
Bon‐Kyoung Koo
,
Hans Clevers
Article
2020
Precision medicine for COVID-19: a call for better clinical trials
Gentle Sunder Shrestha
,
Hem Raj Paneru
,
Jean Louis Vincent
Article
2024
Challenges in conducting efficacy trials for new COVID-19 vaccines in developed countries
Rafael Dal‐Ré
,
Emmanuel Bottieau
,
Odile Launay
,
Frits R. Rosendaal
,
Brigitte Schwarzer‐Daum
Clinical Trials
Discussion(0)
No comments yet. Be the first to comment.